These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 1333302)

  • 21. Fibrinogen binding is independent of an increase in intracellular calcium concentration in thrombin degranulated platelets.
    Pulcinelli FM; Daniel JL; Riondino S; Gazzaniga PP; Salganicoff L
    Thromb Haemost; 1995 Feb; 73(2):304-8. PubMed ID: 7792747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the thrombin-platelet reactions by DuP 714.
    Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate.
    Cattaneo M; Akkawat B; Lecchi A; Cimminiello C; Capitanio AM; Mannucci PM
    Thromb Haemost; 1991 Dec; 66(6):694-9. PubMed ID: 1665598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder.
    Patel YM; Patel K; Rahman S; Smith MP; Spooner G; Sumathipala R; Mitchell M; Flynn G; Aitken A; Savidge G
    Blood; 2003 Jun; 101(12):4828-35. PubMed ID: 12609843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asialo von Willebrand factor binding to and aggregation of platelets: effects of inhibitors of platelet metabolism and function.
    Williams SB; McKeown LP; Gralnick HR
    J Lab Clin Med; 1987 May; 109(5):560-5. PubMed ID: 2437231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton.
    Torti M; Ramaschi G; Sinigaglia F; Lapetina EG; Balduini C
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4239-43. PubMed ID: 8183895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
    Danton MC; Zaleski A; Nichols WL; Olson JD
    J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of heat on platelet biochemistry, structure, and function.
    Rao GH; Smith CM; Escolar G; White JG
    J Lab Clin Med; 1993 Oct; 122(4):455-64. PubMed ID: 8228561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.
    Shattil SJ; Haimovich B; Cunningham M; Lipfert L; Parsons JT; Ginsberg MH; Brugge JS
    J Biol Chem; 1994 May; 269(20):14738-45. PubMed ID: 7514181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.
    Nurden P; Savi P; Heilmann E; Bihour C; Herbert JM; Maffrand JP; Nurden A
    J Clin Invest; 1995 Apr; 95(4):1612-22. PubMed ID: 7706468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. von Willebrand factor is present on the surface of platelets stimulated in plasma by ADP.
    Adelman B; Carlson P; Powers P
    Blood; 1987 Nov; 70(5):1362-6. PubMed ID: 2822171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
    Puri RN; Colman RF; Colman RW
    Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo).
    Altman R; Rouvier J; Weisenberger H
    Thromb Haemost; 1985 Jun; 53(3):312-3. PubMed ID: 3931281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The thienopyridine PCR 4099 selectively inhibits ADP-induced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein IIb-IIIa complex in rat and in man.
    Gachet C; Stierlé A; Cazenave JP; Ohlmann P; Lanza F; Bouloux C; Maffrand JP
    Biochem Pharmacol; 1990 Jul; 40(2):229-38. PubMed ID: 2375765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata.
    Karczewski J; Endris R; Connolly TM
    J Biol Chem; 1994 Mar; 269(9):6702-8. PubMed ID: 8120028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins.
    Heilmann E; Hourdillé P; Pruvost A; Paponneau A; Nurden AT
    Arterioscler Thromb; 1991; 11(3):704-18. PubMed ID: 2029507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
    De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet hyporeactivity in very low birth weight neonates.
    Rajasekhar D; Barnard MR; Bednarek FJ; Michelson AD
    Thromb Haemost; 1997 May; 77(5):1002-7. PubMed ID: 9184418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.